期刊文献+

肾移植术后不同阶段他克莫司缓释剂型转换的回顾研究 被引量:6

A retrospective analysis of the effect of tacrolimus conversion in different periods post-renal transplantation
原文传递
导出
摘要 目的回顾分析肾移植术后不同时期,肾移植受者免疫抑制剂方案由他克莫司转化为他克莫司缓释胶囊的临床特点,为临床肾移植术后免疫抑制剂的治疗给药提供参考。方法根据药物转化的时间,将156例肾移植受者分为三组,比较不同组别换药前后肝肾功能血糖血脂及术后相关指标的影响。结果三组新发糖尿病比例的差异有统计学意义(P=0.025)。免疫诱导方案三组间的差别无统计学意义,免疫抑制剂维持方案三组比较中霉酚酸酯(G3组占68.8%)为主转化为霉酚酸(G1组占72%)为主,差异有统计学意义(P<0.001)。他克莫司用量,三组受者日平均用量(P<0.001)和单位体重的平均用量(P<0.001)差异均有统计学意义。随着术后时间的延长他克莫司平均血药浓度谷值差异有统计学意义(P<0.001)。三组换药的方法差别无统计学意义;G1和G2组换药前后谷值差异有统计学意义。结论肾移植术后不同时期均可选择他克莫司转换他克司缓释剂型的方案,药物剂型的转化降低了佐剂用量,血药浓度及肌酐水平更为稳定,为更优化的免疫抑制方案。 Objective To summarize the clinical characteristics of recipients of renal transplantation who used tacrolimus extended-release capsules, to optimize the postoperative immunosuppressive regimen, and provide reference for the therapeutic administration of immunosuppressive agents after renal transplantation. Methods156 patients who had renal transplant in our center were divided into three groups according to the time of the change of the extended-release tacrolimus capsules, and the blood glucose and blood lipids of each group were analyzed. ResultsThe longer the postoperative duration was, the higher proportion of new-onset diabetes cases (P=0.025). There was no significant difference among the three groups of immune induction regimens. The immunosuppressive regimen was changed from MMF (68.8% in G3 group) to MPA (72% in G1 group). With the prolongation of postoperative time, the dosage of tacrolimus decreased gradually. The mean tacrolimus concentration in the 3 groups was significantly different (P<0.001) as time went by. There was no significant change in the average daily dosage before and after the change. The trough value before and after the change in the first two groups was significantly different (P<0.001). ConclusionThe extended-release tacrolimus capsules could be used in different stages after renal transplantation. After the conversion of the extended-release tacrolimus capsules, the dosage of adjuvant is reduced, and blood concentration and creatinine level are more stablem which is a more optimized immunosuppressive regimen.
作者 付迎欣 曹玉 乜兆玲 冯钢 赵杰 王辉 莫春柏 宋文利 沈中阳 Fu Yingxin;Cao Yu;Nie Zhaoling;Feng Gang;Zhao Jie;Wang Hui;Mo Chunbai;Song Wenli;Shen Zhongyang(Department of Kidney Transplantation,Tianjin First Central Hospital,Tianjin 300192,China)
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2018年第12期734-739,共6页 Chinese Journal of Organ Transplantation
基金 国家自然科学基金青年科学基金项目(81500574) 天津市器官移植临床研究中心项目(15ZXLCSY00070).
关键词 肾移植 他克莫司 免疫抑制剂 回顾性研究 Kidney transplantation Tacrolimus Immunosuppressant Retrospective study
  • 相关文献

参考文献5

二级参考文献41

  • 1周甘平,徐峰.双环醇治疗肾移植术后肝损伤的应用[J].中国药物应用与监测,2004,1(4):7-8. 被引量:1
  • 2李罄,吴笑春,辛华雯,朱敏,余爱荣.联苯双酯滴丸降低肾移植受者全血环孢素A浓度[J].中华器官移植杂志,2005,26(4):243-245. 被引量:8
  • 3Christians U,Jacobsen W,Benet L Z,et al.Mechanism of c-linically relevant drug interactions associated with Tacrolimus[J].Clin Pharmacokinet,2002,41(11):813-851.
  • 4Iwasaki K.Metabolism of tacrolimus(FK506)and recent topics in clinical pharmacokinetics[J].Drug Metab Pharmacokinet,2007,22(5):328-335.
  • 5Xin H W,Wu X C,Li Q,et al.Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers[J].Br J Clin Pharmacol,2007,64(4):469-475.
  • 6Vicari - Christensen M, Repper S, Basile S, et al. Tacrelimus relimus: review of pharmacokinetics, pharmacodynamics, and pharma- cogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence [ J ]. Prog Transplant,2009 ; 19:277 - 284.
  • 7Xin HW, Wu XC, Li Q, et al. Effects of Schisandra sphenanthera extract on the phannacokinetics of tacrolimus in healthy volumteers [J]. Br J Clin Pharmacol, 2007; 64:469 -475.
  • 8Gemtholtz T, Pascoe MD, Botha JF, et al. The use of a cyclosporin - ketoconazole combination : making renal transplantation affordable in developing countries [ J]. Eur J Clin Pharmacol, 2004; 60: 143 - 148.
  • 9Valantine H, Keogh A, Mclntosh N, et al. Cost containment:coadministration of diltiazem with cyclosporine after heart transplantation [ J]. J Heart Lung Transplant, 1992;11:1 -7.
  • 10Capone D, Tarantino G, Gentile A, et al. Effects of voriconazole on tacmlimus rolimus metabolism in a kidney transplant recipient [ J]. J Clin Pharm Ther, 2010;35:121 -124.

共引文献83

同被引文献4

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部